To include your compound in the COVID-19 Resource Center, submit it here.

Hemispherx, Swiss Federal Department of Defense, Civil Protection and Sports (DDPS) infectious news

Hemispherx expanded a research deal with the Swiss agency to test Hemispherx's Alferon N Injection and Ampligen rintatolimod against the Ebola

Read the full 214 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE